{
    "Trade/Device Name(s)": [
        "BIOEASY\u2122 U-Catch MAX Multi-Drug Test Cup",
        "BIOEASY\u2122 U-Catch MAX Multi-Drug Test Cup Rx"
    ],
    "Submitter Information": "Shenzhen Bioeasy Biotechnology Co., Ltd.",
    "510(k) Number": "K230238",
    "Predicate Device Reference 510(k) Number(s)": [
        "K201630",
        "K182530"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "NFT",
        "NFW",
        "NFY",
        "NGG",
        "NGL",
        "NFV",
        "PTG",
        "PTH",
        "NGM",
        "QAW",
        "QBF",
        "DKZ",
        "LDJ",
        "DIO",
        "LAF",
        "JXM",
        "DIS",
        "LAF",
        "LCM",
        "DJR",
        "LFG",
        "JXN"
    ],
    "Summary Letter Date": "March 31, 2023",
    "Summary Letter Received Date": "January 30, 2023",
    "Submission Date": "January 27, 2023",
    "Regulation Number(s)": [
        "21 CFR 862.3650",
        "21 CFR 862.3100",
        "21 CFR 862.3870",
        "21 CFR 862.3250",
        "21 CFR 862.3610",
        "21 CFR 862.3170",
        "21 CFR 862.3150",
        "21 CFR 862.3620",
        "21 CFR 862.3910",
        "21 CFR 862.3700"
    ],
    "Regulation Name(s)": [
        "Opiate Test System",
        "Amphetamine Test System",
        "Cannabinoids Test System",
        "Cocaine and Cocaine Metabolites Test System",
        "Methamphetamine Test System",
        "Benzodiazepine Test System",
        "Barbiturate Test System",
        "Methadone Test System",
        "Tricyclic Antidepressant Drugs Test System",
        "Propoxyphene Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Buprenorphine",
        "Secobarbital",
        "Oxazepam",
        "Cocaine",
        "2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP)",
        "Methamphetamine",
        "Methylenedioxymethamphetamine",
        "Morphine",
        "Methadone",
        "Oxycodone",
        "Phencyclidine",
        "d-Propoxyphene",
        "Nortriptyline",
        "Marijuana (THC)",
        "6-Acetylmorphine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Urine cup"
    ],
    "Instrument(s)/Platform(s)": [
        "BIOEASY\u2122 U-Catch MAX Multi-Drug Test Cup device"
    ],
    "Method(s)/Technology(ies)": [
        "Competitive binding",
        "Lateral flow immunochromatographic assay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Lateral flow"
    ],
    "Submission Type(s)": [
        "Cup",
        "Kit",
        "Device"
    ],
    "Document Summary": "FDA 510(k) summary for BIOEASY\u2122 U-Catch MAX Multi-Drug Test Cup and Rx, lateral flow immunoassays for qualitative multi-drug detection in urine",
    "Indications for Use Summary": "Qualitative and simultaneous detection of multiple drugs and their metabolites in human urine for in vitro diagnostic use; OTC and prescription versions available.",
    "fda_folder": "Toxicology"
}